Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with Rituximab: Report of a case and review of the literature

Rheumatology International

Volumn 29, Issue 12, 2009, Pages 1481-1485

  Rueda, Juan C ^a   Duarte Rey, Carolina ^a   Casas, Nohemi ^a  

^a Unidad de Reumatología   (Colombia)

Author keywords

Anti CD20; Autoimmune pancreatitis; Rituximab; Sj gren's syndrome

Indexed keywords

AMYLASE; DEFLAZACORT; RITUXIMAB; TRIACYLGLYCEROL LIPASE;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE PANCREATITIS; B LYMPHOCYTE; CASE REPORT; CELL FUNCTION; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SJOEGREN SYNDROME; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; FEMALE; HUMANS; PANCREATITIS; RECURRENCE; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 69049117319     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0843-5     Document Type: Article

References (40)

1. H Sarles JC Sarles R Muratore, et al. 1961 Chronic inflammatory sclerosis of the pancreas, an autonomous pancreatic disease? Am J Dig Dis 6 688 698 10.1007/BF02232341
2. K Yoshida F Toki T Takeuchi, et al. 1995 Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis Dig Dis Sci 40 1561 1568 10.1007/BF02285209
3. DL Finkelberg D Sahani V Deshpande, et al. 2006 Autoimmune pancreatitis N Engl J Med 355 2670 2676 10.1056/NEJMra061200
4. T Hayakawa S Naruse M Kitagawa, et al. 2001 Clinical aspects of autoimmune pancreatitis in Sjögren's syndrome JOP J Pancreas Online 2 3 88 92
5. K Uchida K Okazaki Y Konishi, et al. 2000 Clinical analysis of autoimmunerelated pancreatitis Am J Gastroenterol 95 2788 2794 10.1111/j.1572-0241.2000.03187.x
6. K Hirano Y Shiratori Y Komatsu, et al. 2003 Involvement of the biliary system in autoimmune pancreatitis: a follow-up study Clin Gastroenterol Hepatol 1 453 464 10.1016/S1542-3565(03)00221-0
7. T Ito I Nakano S Koyanagi, et al. 1997 Autoimmune pancreatitis as a new clinical entity: three cases of autoimmune pancreatitis with effective steroid therapy Dig Dis Sci 42 1458 1468 10.1023/A:1018862626221
8. RK Pearson DS Longnecker ST Chari, et al. 2003 Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27 1 13 10.1097/00006676-200307000-00001
9. G Zamboni J Luttges P Capelli, et al. 2004 Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens Virchows Arch 445 552 563 10.1007/s00428-004-1140-z
10. D Yadav K Notahara TC Smyrk, et al. 2003 Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection Clin Gastroenterol Hepatol 1 129 135 10.1053/cgh.2003.50016
11. SM Weber O Cubukcu-Dimopulo JA Palesty, et al. 2003 Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma J Gastrointest Surg 7 129 137 10.1016/S1091-255X(02)00148-8 discussion 137-139
12. K Okazaki K Uchida M Ohana, et al. 2000 Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response Gastroenterology 118 573 581 10.1016/S0016-5085(00)70264-2
13. J Kino-Ohsaki I Nishimori M Morita, et al. 1996 Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome Gastroenterology 110 1579 1586 10.1053/gast.1996.v110. pm8613065
14. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society 2000 Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society J Jpn Pan Soc 17 585 587
15. S Aoki T Nakazawa H Ohara, et al. 2005 Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera Histopathology 47 147 158 10.1111/j.1365-2559.2005.02204.x
16. Y Zen K Harada M Sasaki, et al. 2004 IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28 1193 1203 10.1097/01.pas. 0000136449.37936.6c
17. V Deshpande S Chicano D Finkelberg, et al. 2006 Autoimmune pancreatitis: a systemic immune complex mediated disease Am J Surg Pathol 30 1537 1545 10.1097/01.pas.0000213331.09864.2c
18. MH Song MH Kim SK Lee, et al. 2005 Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis Pancreas 30 83 86 10.1097/01.mpa.0000153211.64268.70
19. RK Pearson DS Longnecker ST Chari, et al. 2003 Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27 1 13 10.1097/00006676-200307000-00001
20. SJ Bowman GH Ibrahim G Holmes, et al. 2004 Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK Scand J Rheumatol 33 39 43 10.1080/03009740310004676
21. V Strand N Talal 1980 Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) Bull Rheum Dis 30 1046 1052
22. HM Moutsopoulus 1994 Sjögren's syndrome: autoimmune epithelitis Clin Immunol Immunopathol 72 162 165 10.1006/clin.1994.1123
23. K Nagaraju A Cox L Casciola-Rosen, et al. 2001 Novel fragments of the Sjögren's syndrome autoantigens α-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death Arthritis Rheum 44 2376 2386 10.1002/1529-0131(200110)44: 10〈2376::AID-ART402〉3.0.CO;2-E
24. H Nakamura A Kawakami K Eguchi 2006 Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome: translational research J Lab Clin Med 148 281 288
25. U Bave G Nordmark T Lovgren, et al. 2005 Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism Arthritis Rheum 52 1185 1195 10.1002/art.20998
26. RJ Looney 2007 Will targeting B cells be the answer for Sjögren's syndrome? Arthritis Rheum 56 1371 1377 10.1002/art.22604
27. Anaya JM, Talal N (1997) Sjögren's syndrome and connective tissue diseases associated with other immunologic disorders. In: Koopman W (ed) Arthritis and allied conditions, 13th edn. Williams and Wilkins, Baltimore, pp 1561-1580
28. I Nishimori K Okazaki Y Yamamoto, et al. 1993 Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjögren's syndrome J Clin Immunol 13 265 271 10.1007/BF00919385
29. C Akahane Y Takei A Horiuchi, et al. 2002 A primary Sjögren's syndrome patient with marked swelling of multiple exocrine glands and sclerosing pancreatitis Intern Med 41 749 753 10.2169/internalmedicine.41.749
30. P Chira CI Sandborg 2003 Novel therapies in pediatric rheumatic diseases Curr Opin Pediatr 15 579 585 10.1097/00008480-200312000-00007
31. R Omdal K Wildhagen T Hansen, et al. 2005 Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favorable but temporary response Scand J Rheumatol 34 229 232 10.1080/02813430510015269
32. RF Van Vollenhoven I Gunnarsson E Welin-Henriksson, et al. 2004 Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone Scand J Rheumatol 33 423 427 10.1080/03009740410010227
33. C Kneitz M Wilhelm HP Tony 2004 Improvement of refractory rheumatoid arthritis after depletion of B cells Scand J Rheumatol 33 82 86 10.1080/03009740310004379
34. JE Gottenberg L Guillevin O Lambotte, et al. 2005 Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases Ann Rheum Dis 64 913 920 10.1136/ard.2004.029694
35. GJ Silverman S Weisman 2003 Rituximab therapy and autoimmune disorders Arthritis Rheum 48 1484 1492 10.1002/art.10947
36. F Zaja S De Vita D Russo, et al. 2002 Rituximab for the treatment of type II mixed cryoglobulinemia Arthritis Rheum 46 2252 2254 10.1002/art.10345
37. J Pijpe G Van Imhoff F Spijkervet, et al. 2005 Rituximab treatment in patients with primary Sjogren's syndrome. An open-label phase II study Arthritis Rheum 52 2740 2750 10.1002/art.21260
38. BG Somer DE Tsai L Downs, et al. 2003 Improvement in Sjogren's syndrome following therapy with rituximab for marginal zone lymphoma Arthritis Rheum 49 394 398 10.1002/art.11109
39. M Ramos-Casals A Lopez-Guillermo P Brito-Zeron 2004 Treatment of B-cell lymphoma with rituximab in two patients with Sjogren's syndrome associated with hepatitis C virus infection Lupus 13 969 971 10.1191/0961203304lu2049xx
40. J Pijpe G Van Imhoff A Vissink, et al. 2005 Changes in salivary gland immunohistology and function after rituximab mono-therapy in a patient with Sjogren's syndrome and associated MALT-lymphoma Ann Rheum Dis 64 958 960 10.1136/ard.2004.030684